Has point-of-care come of age?

Point of Care

Volumn 9, Issue 3, 2010, Pages 147-150

  Pothier, Kristin ^a   Kirtland, Mark ^b   Gupta, Sonia ^a  

^a Health Advances   (United States)

^b LIPOSCIENCE INC   (United States)

Author keywords

"test and treat" rapid testing; critical care; diagnostics; emergency department; hand held platform; infectious disease; instrument free platform; physician office testing; POC; Point of care; turn around time; USE ME criteria

Indexed keywords

EID: 77956459662     PISSN: 1533029X     EISSN: 15330303     Source Type: Journal    
DOI: 10.1097/POC.0b013e3181f381ff     Document Type: Article

References (5)

1. Laboratory Market Leaders Report 2008. New York: Washington G-2 Reports; 2007.
2. Mueller C, Scholer A, Laule-Kilian K, et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med. 2004;350:647-654.
3. Lewandrowski K, Flood J, Finn C, et al. Implementation of point-of-care rapid urine testing for drugs of abuse in the emergency department of an academic medical center: impact on test utilization and ED length of stay. Am J Clin Pathol. 2008;129:796-801.
4. Centers for Disease Control and Prevention (CDC). HIV CT client record reports, 2000, US Total. 2000. Available at: http:// www.cdc.gov/hiv/pubs/rt- counseling.htm. Accessed June 1, 2009.
5. Lee-Lewandrowski E, Lewandrowski K. Perspectives on cost and outcomes for point-of-care testing. Clin Lab Med. 2009;29(3):479-489.